Spinal devices maker Benvenue Medical closed a $3.5 million funding round with the help of 9 unnamed investors, according a regulatory filing.
The Santa Clara, Calif.-based company raised the funds through sales of debt, rights and securities or rights to acquire securities. Benvenue provided few other details on the funding round.
The privately held spinal devices maker, launched in 2004, designs and manufactures minimally invasive spinal repair devices. Its flagship Kiva VCF system is an "implant-based approach to vertebral augmentation in the treatment of painful [vertebral compression fractures]."
Benvenue announced last month that its Kiva system was reportedly non-inferior to balloon kyphoplasty in managing pain associated with osteolytic vertebral body metastases, while resulting eliminating incidents of cement leakage.
The Kiva System won FDA 510(k) clearance last month, and is also available in Europe, where it’s distributed by medtech titan Zimmer (NYSE:ZMH).
